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Phoneutria nigriventer toxin Tx1 (PnTx1, also referred to in the literature as Tx1) exerts inhibitory effect
on neuronal (NaV1.2) sodium channels in a way dependent on the holding potential, and competes with
m-conotoxins but not with tetrodotoxin for their binding sites. In the present study we investigated the
electrophysiological properties of the recombinant toxin (rPnTx1), which has the complete amino acid
sequence of the natural toxin with 3 additional residues: AM on the N-terminal and G on the C-terminal.
At the concentration of 1.5 mM, the recombinant toxin inhibits Naþ currents of dorsal root ganglia
neurons (38.4  6.1% inhibition at 80 mV holding potential) and tetrodotoxin-resistant Naþ currents
(26.2  4.9% at the same holding potential). At 50 mV holding potential the inhibition of the total
current reached 71.3  2.3% with 1.5 mM rPnTx1. The selectivity of rPnTx1 was investigated on ten
different isoforms of voltage-gated sodium channels expressed in Xenopus oocytes. The order of potency
for rPnTx1 was: rNaV1.2 > rNaV1.7 z rNaV1.4  rNaV1.3 > mNaV1.6  hNaV1.8. No effect was seen on
hNaV1.5 and on the arthropods isoforms (DmNaV1, BGNaV1.1a and VdNaV1). The IC50 for NaV1.2 was
33.7  2.9 nM with a maximum inhibition of 83.3  1.9%. The toxin did not alter the voltage-dependence
of channel gating and was effective on NaV1.2 channels devoid of inactivation. It was ineffective on
neuronal calcium channels. We conclude that rPnTx1 has a promising selectivity, and that it may be
a valuable model to achieve pharmacological activities of interest for the treatment of channelopathies
and neuropathic pain.
 2012 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
Sodium channels form a super family of membrane proteins
specialized in electrical signaling and ionic homeostasis. These
channels are highly selective for Naþ ions and their probability of
opening depends on membrane potential and time, what makes
them key elements for the initiation and propagation of the action
potential in excitable cells. Nine subtypes of mammalian voltage-
dependent sodium channels were identiﬁed and characterized
(NaV1.1eNaV1.9). Each isoform can be distinguished for its
pharmacological properties and functional characteristics. Morein 1; rPnTx1, recombinant
IIIA; SIIIA, m-conotoxin SIIIA;
tetraethyl ammonium; NaV,
.
nder the Elsevier OA license.importantly, many subtypes of sodium channels are specialized,
so that speciﬁc blocking agents may alter some physiological
functions while preserving others. Alterations in the activity or
expression of voltage-gated sodium channel subtypes are associ-
ated with several pathological conditions such as epilepsy, stroke
and neuropathic pain. Because of their high afﬁnity and speciﬁcity,
neurotoxins may be powerful tools to study ion channels, through
the understanding of their mode of action and identiﬁcation of
their molecular binding sites to ion channel, and are potential
models for the development new drugs [1e3].
Interesting biological activities can be found in animal venoms.
Among them, the venom of the spider Phoneutria nigriventer has
been shown to be a rich source of peptides with diverse biological
activities [4,5]. In contrast, its drawback is that the amount of each
toxin found in the venom is very low. Added to the fact that the
volume of venom produced by each spider is small, it becomes
difﬁcult to purify and identify the structure and biological proper-
ties of each peptide.
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expression of the toxic peptide. The expression of the P. nigriventer
toxin Tx1 (PnTx1) was an important step to express cysteine-rich
toxins [6]. The recombinant toxin (rPnTx1) has the complete
amino acid sequence of the natural toxin with 3 additional resi-
dues: AM on the N-terminal and G on the C-terminal, and molec-
ular mass of 8858.10  0.33 Da. It was shown to reproduce the
neurotoxic symptoms of the native toxin: tail elevation, excitation,
salivation and spastic paralysis, when administered by
intracerebro-ventricular injection on mice [6,7]. PnTx1 has
a molecular mass of 8594.6 Da, 78 amino acid residues, 14 of which
are cysteines. Its inhibitory activity on sodium channels has been
reported, with the important detail that the inhibition is enhanced
by depolarization of the membrane [8]. An inhibitory effect on
calcium channels had been reported previously [9,10]. This effect
was later attributed to the presence of a very small contamination
with PnTx3-3 [8], already described as a potent calcium channel
inhibitor [11]. However, the possibility that it is a promiscuous
toxin remained, because PnTx1 shares sequence similarity with
other toxins known to inhibit calcium channels [5].
In the present work, we report for the ﬁrst time the subtype and
phyla selectivity of this unique and potent spider recombinant
toxin, which has the following order of potency:
rNaV1.2 > rNaV1.7 z rNaV1.4  rNaV1.3 > mNaV1.6  hNaV1.8. No
effect was observed on hNaV1.5 and arthropod isoforms. Taking
advantage that rPnTx1 is devoid of contamination with other
toxins, we veriﬁed that it has no signiﬁcant effect on Ca2þ currents.
Given the maintenance of full activity of the recombinant toxin, the
present work opens new promising perspectives to the study of
structureeactivity relationship and to engineering rPnTx1 in order
to improve its selectivity by site-directed mutagenesis.
2. Materials and methods
2.1. Expression construct and protein expression
The protocol used is the same described by Diniz and colleagues
[6] with modiﬁcations [12]. Brieﬂy, the 250-bp DNA sequence
encoding the mature PnTx1 was ampliﬁed by PCR using speciﬁc
primers, sense 50-AGAGAGAGACCATGGCCGAGTTAACGAGCTGC-30
and antisense 50-GAGAGAGGATCCTTAGCAATTTCTCCTGCAGGG-30
that included 50Nco1 and 30BamH1 restriction enzyme sites,
respectively. The ampliﬁed product was cleaved with Nco1 and
BamH1, ligated into similarly digested pET32c(þ) and used to
transform Escherichia coli NM22 cells and cultured into Luriae
Bertani (LB) medium, containing 100 mg/ml of ampicillin at 37 C.
The PCR selected clones were certiﬁed by DNA sequencing [13]
using an automated DNA sequencer (ALFexpress DNA sequencer,
Amersham Pharmacia Biotech) following the manufacturer’s own
protocol and reagents. Isolated expression construct was used to
transform competent cells of E. coli, the expression host
(AD494(DE3)pLysS). Individual clones were grown at 37 C in LB
medium containing 100 mg/ml ampicillin and 34 mg/ml chloram-
phenicol until A600 of approximately 0.5 (cell density of
5 108 cells/ml). Cells were induced by the addition of isopropyl b-
D-thiogalactoside (IPTG) to a ﬁnal concentration of 1 mM. Cells
were harvested 2e2.5 h after the addition of IPTG and the pellets
were then frozen at 70 C. Induced frozen cells were thawed and
re-suspended in 5 mM imidazole, 0.5 M NaCl and 20 mM TriseHCl,
pH 7.9 (binding buffer) and the cells were lysed by sonication. After
centrifugation, the supernatant containing soluble recombinant
fusion protein was loaded onto Histrap HP Chelating afﬁnity
column (Amersham Biosciences, HPLC) charged with 500 mM
NiSO4 and equilibratedwith binding buffer. Unbound proteins were
eluted from the chelating column with binding buffer. Fusionproteins were eluted with linear gradient of 500 mM imidazole,
0.5 M NaCl and 20 mM NaHPO4, pH 7.4 (elution buffer) and the
fractions containing thioredoxinerPnTx1 fusion protein were
detected by PAGE-SDS 12.5% (w/v). The fractions containing
thioredoxinerPnTx1 fusion protein were pooled, further puriﬁed
and desalted by gel ﬁltration chromatography (Hitrap HP
Desalting, Amersham Biosciences, HPLC) and lyophilized. After
cleavage with enterokinase (following the Novagen protocol), the
products were subjected to reverse-phase chromatography
(Sephasil Peptide C18 5 m ST 4.6/250; HPLC). The recombinant
protein was detected by mass spectrometry MALDI-TOF analysis
and used for biological tests.
2.2. Culture of rat dorsal root ganglia (DRG) neurons
Male Wistar rats (250e300 g) were maintained in a controlled
environment (circadian cycle, 25 C, food and water ad libitum), 2
animals in each cage. All procedures involving animals were in
accordance with the guidelines provided by the regulations on
ethics and animal experimentation of the Brazilian Government.
Neurons of DRG were dissociated and used as described previ-
ously [14]. The DRG were isolated and maintained in Ca2þ-free
modiﬁed Ringer solution containing (in mM) NaCl 140, KCl 2.5,
HEPES 10, and glucose 7.5, pH adjusted to 7.4 with NaOH. The
enzymatic treatment was done with papain (1 mg/ml, Sigma),
activated by cysteine (0.03 mg/ml, Sigma) in Ca2þ-free Ringer, fol-
lowed by enzymatic treatment with 2.5 mg/ml collagenase (Type
1A, Sigma) in Ca2þ-free Ringer, for 20 min each one.
Digested ganglia fragments were suspended in 1 ml of F12
medium containing 10% fetal bovine serum (Cripion, São Paulo,
Brazil) and dissociated by passing through ﬁre polished pipettes
(inner tip diameter of 2 mm). The cell suspension thus obtained
was plated onto glass coverslips previously treated with poly-L-
lysine (MW 70,000e150,000, 0.1% v/w, for 12 h at 4 C) followed by
laminin (20 mg/ml, for 6 h at 4 C). The cells were stored for 2 h at
37 C in a 5% CO2 incubator. After this period, the medium was
changed to L15 medium containing 10% fetal bovine serum, peni-
cillin (100 units/ml) and streptomycin (100 mg/ml). The cultures
were stored at room temperature and used within 48 h.
2.3. Heterologous expression of sodium channels
The oocytes were surgically removed from anaesthetized adult
female frogs Xenopus laevis. Stage V and VI oocytes were selected
and injected with 50 nl of RNA at a concentration of 1 ng/nl using
a micro-injector (Drummond Scientiﬁc, USA). For the expression,
the rNaV1.2/pCLT1, rNaV1.3/pNa3T, rNaV1.4/pUI-2, mNaV1.6/pLCT1,
hNaV1.8/pBSTA, DmNaV1/pGH19, BgNaV1.1/pGH19 and VdNaV1/
pGH19 vectors were linearized with Not I. The rNaV1.7/pBSTA, and
hb1/pGEM-HE vectors were linearized with Sac II and Nhe I,
respectively. These vectors were transcribed with the T7
mMESSAGE-mMACHINE transcription kit (Ambion). The hNaV1.5/
pSP64T and rb1/pSP64T constructs were linearized with Xba I and
Eco RI, respectively, and transcribed with the SP6 mMESSAGE-
mMACHINE transcription kit (Ambion). The oocytes were incu-
bated in a solution containing (in mM): NaCl, 96; KCl, 2; CaCl2, 1.8;
MgCl2, 2 and HEPES, 5 (pH 7.4), supplemented with 50 mg/l gen-
tamycin sulfate and 180 mg/l theophylline.
2.4. Electrophysiology
2.4.1. DRG neurons
Sodium currents were recorded using the patch clamp tech-
nique in the modality whole cell with an Axopatch 200B ampliﬁer
controlled by PClamp 6 software (Molecular Devices, Sunnyvale,
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pipette puller (PP 830 Narishige, Tokyo, Japan) and had resistances
of 1.0e1.5 MU. The elicited currents were sampled at 10 kHz and
ﬁltered at 5 kHz using a four-pole low-pass Bessel ﬁlter. Pipette
solution contained (in mM) CsF 100, NaCl 20, HEPES 10, EGTA 11,
tetraethyl ammonium chloride (TEA-Cl) 10, MgCl2 5, pH 7.2 with
CsOH. Whole-cell recording conditions were obtained at extracel-
lular solution containing (in mM) NaCl 115, KCl 5, CaCl2 2, MgCl2 1,
HEPES 10, TEA-Cl 20, CdCl2 0.2, NiCl2 0.2, glucose 5, pH 7.4 adjusted
with NaOH. After establishing the whole-cell conﬁguration, the
bath solution was changed to one containing 30% (v/v) of the
extracellular solution described above and 70% (v/v) Na-free
extracellular solution containing (in mM) choline chloride 115,
KCl 5, CaCl2 2, MgCl2 1, HEPES 10, TEA-Cl 20, CdCl2 0.2, NiCl2 0.2,
glucose 5, pH 7.4 adjusted with choline hydroxide. The ﬁnal
extracellular Naþ concentration was 34.5 mM.
Unless otherwise stated, the cell under examination was held
at80mV andmaintained under continuous perfusion, either with
control or experimental solution. In order to elicit Naþ currents,
a pre-pulse of 100 mV was applied for 100 ms, to remove inac-
tivation, and was followed by the test pulse, whose values and
durations are shown in each ﬁgure. Leak subtraction was per-
formed using a P/4 protocol. This protocol was carried out every 5 s.
For recording calcium currents, the pipette solution was (mM):
CsCl 140, HEPES 10, ATP Li e creatine phosphate 10; pH 7.4 adjusted
with CsOH. The external solution contained (mM): TEA-Cl 132,
CaCl2 2, CsCl 4, HEPES 10, Glucose 11, MgCl2 1; pH 7.4 adjusted with
TEA-OH. The holding potential utilized was 80 mV. In order to
observe the effect of rPnTx1 on calcium currents, the test pulse
was 20 mV for 200 ms.
2.4.2. X. laevis oocytes
For electrophysiological experiments in oocytes, two-electrode
voltage clamp recordings were performed at room temperature
using a Gene Clamp 500 ampliﬁer (Molecular Devices, Sunnyvale,
California, USA) controlled by a pClamp10 data acquisition system
(Molecular Devices). Voltage and current electrodes were ﬁlled
with 3 M KCl. Resistances of both electrodes were kept between 0.5
and 1.5 MU. The elicited currents were sampled at 20 kHz and
ﬁltered at 2 kHz using a four-pole low-pass Bessel ﬁlter. The
external solution consisted of (mM): NaCl 96, KCl 2, MgCl2 1, CaCl2
1.8, HEPES 5; adjusted to pH 7.5 with NaOH.
To evoke sodium current, standard voltage clamp protocols
were used, from a holding potential of90mV andwith 5 s interval
between each test. Sodium current traces were evoked by 100 ms
depolarization to 0 mV. The currentevoltage relationships were
determined by 50 ms step depolarizations between 90 and
70 mV, using 5 mV increments.
To analyze the voltage-dependence of activation, the sodium
conductance (gNa) was calculated by linear regression of the ohmic
segment of the currentevoltage (IeV) relationship. Using the ob-
tained parameters, INa(max) was calculated by extrapolation of the
current to each potential. The fraction of channels activated was
given by INa/INa(max), where INa is the measured peak Naþ current
and INa(max) is the expected current if all channels were open. The
data were ﬁtted to a Boltzmann equation: INa/INa(max) ¼ 1/
[1 þ (exp(Vg  Vp)/kg)], where Vg is the voltage corresponding to
half-maximal conductance, Vp is the test pulse potential and kg is
the slope factor.
Toxin-induced effects on the steady-state inactivation were
investigated using a standard two-step protocol. In this protocol,
200 ms conditioning pre-pulses ranging from 90 to 65 mV (with
5 mV increments) were followed by a 100 ms test pulse to 0 mV.
Datawere normalized to themaximal Naþ current amplitude (Imax),
plotted against the pre-pulse potential and ﬁtted using theBoltzmann equation: INa/Imax ¼ 1/[1 þ exp((Vc  Vh)/kh)], where Vh
is the voltage corresponding to half-maximal inactivation, Vc is the
conditioning pre-pulse voltage and kh is the slope factor.
2.4.3. Data analysis
For doseeresponse graphics, we used the simple rectangular
hyperbolic equation:
y ¼max*c/(IC50 þ c), where max is the maximum effect, c is the
toxin concentration and IC50 is the concentration that produces
half-maximal effect.
Curve-ﬁtting was achieved using Sigma Plot software. Data are
presented as mean  SEM in the text and in the ﬁgures. Results
were analyzed using Student’s paired t test. Unless otherwise
stated, differences were considered statistically signiﬁcant when
P < 0.05.
3. Results
3.1. Effect of recombinant toxin in DRG neurons
Our ﬁrst step was to check the effect of recombinant toxin in
DRG neurons. Among the population of neurons found in the
dissociated ganglia, cells with smaller diameters are an interesting
model for experimental studies since they express both
tetrodotoxin-sensitive sodium channels (TTX-S) (NaV1.1, NaV1.2,
NaV1.6 and NaV1.7) and TTX-resistant channels (TTX-R) (NaV1.8 and
NaV1.9) [15,16], and are involved in the transmission of pain signals
to the central nervous system [16]. Fig. 1A shows the typical
inhibitory effect of 3 mM rPnTx1 on Naþ currents of DRG neurons. In
order to verify the toxin effect on TTX-R currents, DRG neurons
were perfused with external solution containing 300 nM TTX,
which is enough to inhibit TTX-S currents, and subsequently
perfused with the same solution to which rPnTx1 was added. The
effect of 3 mM rPnTx1 is shown in Fig. 1B. At the concentration of
1.5 mM, the average inhibition of rPnTx1 was 38.4  6.1% and
26.2  4.9% on total and on TTX-R Naþ currents, respectively. The
concentration-dependence of the inhibitory effect on DRG Naþ
currents is shown in Fig. 1D. The results were ﬁtted with the rect-
angular hyperbolic equation (Material and methods) and the best
ﬁt was obtained with the IC50 of 0.6 mM and maximal inhibition of
44.2  5.6%.
In order to investigate if the effect of the recombinant toxin is
dependent on the state of the channel, Naþ currents were elicited in
cells with holding potential of 50 mV. The same pulse protocol
was used, including the conditioning 100ms pre-pulse to100mV.
The inhibitory effect of 1.5 mM rPnTx1 is shown in Fig. 1C. With this
protocol, the percentage of inhibition at 1.5 mM rPnTx1 was
71.3  2.3%. For comparison, this result is shown in Fig. 1D (open
symbol).
3.2. rPnTx1 effect on different NaV channel isoforms
To determine the phyla and subtype selectivity of rPnTx1, it was
subject of an extensive study on a wide panel of 10 different iso-
forms of NaV channels. Fig. 2 shows that this toxin exerts greater
effect on NaV1.2 channels: at the concentration of 1 mM the toxin
could inhibit 83.3  1.9% of the sodium current through these
channels. Higher concentrations of toxin could not increase the
percentage of inhibition, suggesting that it attained a saturating
concentration. Interestingly, the residual current could be blocked
with 100 nM of TTX (data not shown). This phenomenon has been
shown by Martin-Moutot and colleagues [8] using the natural
toxin. Although with lower afﬁnity, rPnTx1 could also inhibit
NaV1.3, NaV1.4 and NaV1.7 with similar potencies (54.3  5.9%,
63.2  5.3% and 65.4  4.8%, respectively). NaV1.6 and NaV1.8 were
Fig. 1. Effect of rPnTx1 on Naþ currents of DRG neurons. (A) Representative Naþ currents before (black line) and 10 min after (gray line*) the addition of 3 mM rPnTx1. Holding
potential: 80 mV. (B) Representative TTX-resistant Naþ currents before (black line) and 10 min after (gray line*) the addition of 3 mM rPnTx1. Holding potential: 80 mV. (C)
Representative experiment on cell held at 50 mV. Naþ currents before (black line) and 10 min after (gray line*) the addition of 1.5 mM rPnTx1. (D) Concentrationeresponse
relationship. Closed symbols, holding potential 80 mV; open symbol, holding potential 50 mV. Data were ﬁtted using the rectangular hyperbolic equation shown in Material and
methods. Best ﬁt was achieved with max ¼ 44.2  5.6% and IC50 ¼ 0.6 mM. In all experiments the test pulse potential was 10 mV.
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a small percentage of the current (32.8  4.3% and 26.6  8.2%,
respectively). Interestingly, rPnTx1 was not signiﬁcantly active on
NaV1.5, even at concentrations up to 5 mM.
Similarly, rPnTx1 was also inactive on several arthropod NaV
channel isoforms. At 1 mM the toxin failed to decrease the current
peak amplitude of sodium channels from the following arthropods:
fruit ﬂy Drosophila melanogaster (DmNaV1), cockroach Blattella
germanica (BgNaV1.1a) and mite Varroa destructor (VdNaV1) (Fig. 2).
3.3. Analysis of the effect of rPnTx1 on activation and inactivation of
NaV1.2
As pointed out, rPnTx1 has a higher afﬁnity to NaV1.2 subtype.
Therefore we used this isoform to further investigate whether the
rPnTx1 induced inhibition is caused by altering the voltage-
dependence of channel gating. Fig. 3A shows the currentevoltage
relationship in the presence and absence of 20 nM rPnTx1. There
is a marked decrease of the peak current and maximum conduc-
tance to Naþwithout signiﬁcant change in the voltage dependence.
This is better explored in Fig. 3B, that shows no signiﬁcant differ-
ence between the Vg of activation control conditions(Vg ¼ 26.78  0.28 mV) and after the addition of 1 mM rPnTx1
(V1g ¼ 26.32  0.43 mV). Fig. 3C shows no signiﬁcant shift in the
midpoint of the voltage-dependence of the steady-state inactiva-
tion caused by rPnTx1.
3.4. Comparison of the potency of the native and recombinant
toxins
Since the recombinant toxin was produced in bacteria and has
its amino acid sequence slightly modiﬁed, it is important to verify
whether it retains the same effectiveness of the native toxin. Native
PnTx1 puriﬁed as previously described [7] was used. Both peptides
could inhibit NaV1.2 channels with the same efﬁcacy (maximal
inhibition of PnTx1: 85.0 0.8%; rPnTx1: 83.31.9%). Interestingly,
the IC50 of recombinant toxin (IC50 ¼ 33.7  2.9 nM) was slightly
but signiﬁcantly lower than the IC50 of native toxin
(IC50 ¼ 105  12 nM) (Fig. 4).
3.5. Effect of rPnTx1 in NaV1.2 channels devoid of fast inactivation
In order to investigate if the action of rPnTx1 might be through
stabilizing the inactivated state, NaV1.2 channels with a mutation
Fig. 2. Effect of rPnTx1 on different subtypes of sodium channels expressed in oocytes. (A) Representative records of Naþ currents before (black line) and after (gray line*) the
addition of 1 mM rPnTx1. Dashed line is the baseline. Holding potential: 90 mV. Test potential: 0 mV. (B) Average percentage of Naþ current inhibition by rPnTx1 (1 mM) of different
sodium channel subtypes expressed in oocytes. NaV1.2 inhibition was signiﬁcantly higher when compared with NaV1.3, NaV1.4 and NaV1.7 and these were higher when compared
with NaV1.6 and NaV1.8. No effect was observed with NaV1.5 and with the arthropod isoforms (DmNaV1, BgNaV1.1a and VdNaV1). The symbols (*), (**) and (***) denote the isoforms
on which the toxin effects were not statistically different.
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records in both control and experimental conditions showed
sodium currents devoid of fast inactivation, and the inhibitory
effect of 1 mM rPnTx1 can be clearly seen (74.0  3.0% inhibition,
n ¼ 3), although a little smaller than that observed with NaV1.2
channels without mutation (Fig. 4).3.6. Effect of rPnTx1 in calcium channels present in DRG neurons
The amino acid sequence of PnTx1 has a similarity with the
amino acid sequence of u-agatoxin IIIA, which blocks calcium
channels [5]. Previous articles suggested an effect of PnTx1 on
neuronal calcium channels [9,10]. Martin-Moutot and colleagues
[8] suggested that this effect is due a contamination with PnTx3-3,
a toxin of P. nigriventer reported to be a potent inhibitor of calciumchannels [11]. The recombinant toxin provides an interesting
opportunity to solve the issue, since it is produced in a heterologous
system free from contaminationwith other toxins. Fig. 6 shows that
1 mM rPnTx1 does not alter signiﬁcantly the calcium current of DRG,
suggesting that this toxin is not promiscuous.4. Discussion
The present article is the ﬁrst electrophysiological study to
characterize the effect and selectivity of the recombinant toxin
rPnTx1 on different NaV channel isoforms. The experiments were
carried out both on constitutively expressed sodium channels of
DRG neurons and on isoforms expressed in Xenopus oocytes. DRG
neurons express both TTX-S and TTX-R channels [15,16] and the
latter proved to be less sensitive to rPnTx1. The recombinant toxin
Fig. 3. Kinetic analysis of NaV1.2 inhibition. (A) Effect of rPnTx1 on the Naþ currente
voltage relationship before (black symbols) and after (gray symbols) the addition of
1 mM rPnTx1. Average  SEM of 3 pared experiments. All values are normalized to the
maximum peak current of the corresponding cell. (B) Effect of rPnTx1 on the voltage-
dependence of activation before (black symbols) and after (gray symbols) the addition
of 50 nM rPnTx1. Average SEM of 5 paired experiments. The data were ﬁtted with the
Boltzmann equation (Material and methods), with the best ﬁts of
Vg ¼ 26.78  0.28 mV and 26.32  0.43 mV mV, kg ¼ 5.11  0.25 and 6.11  0.38, for
control and experimental, respectively. (C) Voltage-dependence of the steady-state
inactivation before (black symbols) and after (gray symbols) the addition of 50 nM
rPnTx1. Average  SEM of 3 paired experiments. The data were ﬁtted with the
Boltzmann equation (Material and methods), with the best ﬁts of: Vh ¼ 48.47  0.51
and 48.37  0.54 mV, kh ¼ 7.6  0.45 and 9.7  0.5, for control and experimental,
respectively.
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strongly supports the interpretation that the previously reported
effect on this type of channel was due to the contamination of the
puriﬁed toxin with a calcium selective toxin [8].
Although native toxins are important tools to investigate ion
channels, the possibility of expressing recombinant toxins has
several important advantages, such as the possibility of having
larger amount of material without contamination with differenttoxins and, more importantly, the possibility of making well
designed mutations in order to carry out structure-function studies
and alter the toxin properties. The major difﬁculty to overcome is
obtaining the correct folding of the recombinant toxin and the
same activity as the native one. This is especially difﬁcult with
spider toxins, particularly with P. nigriventer toxins, that have high
proportion of cysteines forming disulﬁde bridges [4]. In most
attempts to express these toxins they came out with low or no
activity. The expression of rPnTx1 is an important achievement,
since it is a large (81 amino acids) peptide, with 7 disulﬁde bonds,
as inferred by the comparison of its formula weight (8872.25 Da)
and the measured molecular mass (8858.10 Da). Despite these
difﬁculties, our results show that the recombinant toxin has even
slightly higher afﬁnity than the native one on NaV1.2 channels, as
shown in Fig. 4. Due to the very limited amount of PnTx1, it was not
possible to carry out structural comparisons.
Even more appealing is the observation that rPnTx1 shows
a signiﬁcant selectivity toward neuronal sodium channels. The
following order of rPnTx1 sensitivity was obtained:
rNaV1.2 > rNaV1.7 z rNaV1.4  rNaV1.3 > mNaV1.6  hNaV1.8. No
signiﬁcant effect was seen on the cardiac NaV1.5. Similarly, it had no
activity on arthropod channels. Of great interest is its high selec-
tivity toward Nav1.7 channels, because of its involvement in acute
and inﬂammatory pain [17]. The higher afﬁnity to the NaV1.2
subtype was also observed with the m-conotoxins KIIIA (Conus
kinoshitai) [18] and SIIIA (Conus striatus) [19]. By comparing the
sequence of both toxins, one can observe an important similarity of
the conotoxin KIIIA with a central segment of PnTx1 (Fig. 7). In fact,
we can identify a sequence containing the amino acids W33, R35
and K39 that align with similar amino acids W8, R10 and R14,
respectively, present in the m-conotoxin KIIIA [20,21]. Single
mutations can alter signiﬁcantly the selectivity of a toxin. The
substitution tryptophan at position 8 by arginine decreased afﬁnity
of m-conotoxin KIIIA for NaV1.2 subtype, making it more selective to
NaV1.4 [22]. Nonetheless, many structural questions about rPnTx1
remain open, which makes it an attractive object for further
investigation.
Functional and competition experiments have characterized six
toxin binding sites on sodium channels [2,3]. TTX and m-conotoxins,
compete for the same site (site 1) and cause a blockage of the
sodium channel pore. In the work published byMartin-Moutot and
colleagues [8], binding experiments showed that PnTx1 competed
with the m-conotoxin GIIIB and not with TTX. TTX competes with
the conotoxin, which loses its ability to displace PnTx1 in the
presence of excess of TTX. This means that PnTx1 and the m-con-
otoxins have different but overlapping sites.
The possibility that PnTx1 inhibits Naþ currents by altering
gating mechanisms was especially important to be considered
since the effects of PnTx1 are more pronounced at depolarized
holding potentials [8], what is also seenwith the recombinant toxin
(Fig. 1). One possible mechanism could be the stabilization of the
inactivated state. The experiment in Fig. 5 shows that rPnTx1
markedly inhibits sodium channels devoid of fast inactivation, thus
excluding the possibility of stabilizing the fast inactivated state.
Another feature of rPnTx1that is similar to m-conotoxins KIIIA
and GIIIA is the fact that the inhibition is not complete even at
saturating concentrations. Fig. 4 shows that the maximal inhibition
of NaV1.2 channels is 85.0% and 83.3% for the native and recombi-
nant toxins, respectively. Since the NaV1.2 channels expressed
consist of homogenous populations, it means that the inhibition of
each channel is incomplete. This could happen by the decrease of
single channel conductance or by alteration of gating kinetics. The
voltage-dependences of activation and steady-state inactivation of
sodium currents are not altered by the recombinant toxins, which
makes it unlikely that the gating and open time probability are
Fig. 4. Comparison of the effects of rPnTx1 and the puriﬁed PnTx1 on NaV1.2 channels. (A) Representative trace of the currents before (black) and after (gray*) the addition of 1 mM
rPnTx1. (B) Representative trace of the currents before (black) and after (gray*) the addition of 1 mM PnTx1. (C) Concentration-dependence of the effect of PnTx1 (black symbols) and
rPnTx1 (gray symbols). The data were ﬁtted with the quadratic equation shown in Material and methods. Best ﬁts were achieved with max ¼ 85.0  0.8% and 83.3  1.9%,
IC50 ¼ 105  12 nM and 33.7  2.9 nM for PnTx1 and rPnTx1, respectively.
A.O. Silva et al. / Biochimie 94 (2012) 2756e27632762altered by the toxins (Fig. 3). Additionally, PnTx1 was shown not to
competewith toxins that modify sodium channel gating [9], such as
a-scorpion toxins (site 3) and b-scorpion toxins (site 4) [23e25].
A likelymechanism of action is that it reduces the single channel
conductance, in a manner similar to that shown for m-conotoxin
GIIIA [26] and KIIIA [18], which bind to site 1. Furthermore,
experiments show that TTX is able to bind to the channel even in
the presence of m-conotoxins KIIIA, leading to complete inhibition
of residual sodium current [27]. A model has been proposed that
can account for these observations, based on the fact that these
toxins are large compared to TTX. The model predicts that it can
bind at the outer vestibule of the channel without its complete
occlusion, thus allowing the channel to be activated but restricting
the passage of Naþ ions [26e28]. It can also allow TTX to pass to its
binding site, probably located deeper in the outer pore, thus
causing its blockage. One can anticipate that mapping the sites ofFig. 5. Effect of rPnTx1 on NaV1.2 channels devoid of fast inactivation. Representative
current records before (black) and after (gray*) the addition of 1 mM rPnTx1 to oocytes
expressing NaV1.2 channels mutated to remove fast inactivation. The dashed line
represents the baseline.interaction of P. nigriventer toxin will provide important insights
into the toxin binding site and the structure of the channel outer
vestibule [3]. The selectivity shown by rPnTx1 means that the outer
region of the pore is not equal in all channel isoforms, and provide
grounds for searching for more speciﬁc drugs.
The effect of depolarized holding potential remains to be clari-
ﬁed (Fig. 1D). A likely explanation is the alteration of its binding site
as a consequence of the depolarized potential. This phenomenon
may be of much interest, because the effect of PnTx1 will be more
prominent on cells that remain depolarized longer times, which is
invaluable in augmented activation of neurons, such as in neuro-
pathic pain.
In fact, studies with the m-conotoxins previously mentioned,
have shown that they have a potent analgesic effect [18,20]. This
opens an interesting possibility to the use of rPnTx1. It is possible to
perform assays with site directed mutations to make the toxin
more speciﬁc to subtypes of sodium channels of interest. Thus
the rPnTx1 becomes a promising tool for the development ofFig. 6. Effect of rPnTx1 1 mM on Ca2þ current of DRG neurons. Representative Ca2þ
current recorded before (black) and 10 min after (gray*) the addition of 1 mM rPnTx1.
The baseline is represented by the dashed line. The test pulse was 20 mV for 200 ms.
Fig. 7. Sequence alignment of rPnTx1 with KIIIA. Identical amino acids are highlighted
with dark gray background and similar ones with light gray background. The three
additional amino acids not present in the natural PnTx1 are underlined.
A.O. Silva et al. / Biochimie 94 (2012) 2756e2763 2763analgesics, or as model for new drugs. On the other hand, abnormal
channel NaV1.2 expression is related with severe myoclonic
epilepsy of infancy (Dravet syndrome), intractable childhood
epilepsy with frequent generalized tonic-clonic seizures and
benign familial neonatal-infantile seizures [29]. Patients with these
diseases may beneﬁt from drugs developed from rPnTx1 studies.
5. Conclusion
In this study we found that the rPnTx1 has similar effects as the
native toxin PnTx1, with signiﬁcant selectivity to the TTX-sensitive
channels NaV1.2, NaV1.7, NaV1.4 and NaV1.3, and no effect on iso-
form NaV1.5 and arthropod sodium channels. This toxin has
a greater afﬁnity to NaV1.2 subtype, with an IC50 of 33 nM. Since
there are a number of channelopathies involving these channels,
the expression of rPnTx1 opens a new perspective for under-
standing speciﬁc characteristics of the channel and the develop-
ment of new drugs.
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